Results 151 to 160 of about 14,294,829 (187)

Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferation. [PDF]

EJHaem
Zhao X, Jagadeesh D, Bodo J, Durkin L, Lindner DJ, Ondrejka SL, Hsi ED.   +6 more
europepmc   +1 more source

Low levels of CD3 + and CD8 + T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma. [PDF]

Ann Hematol
Liu Y, Song W, Song Y, Zhu J, Xie Y.
europepmc   +1 more source

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm. [PDF]

Front Pharmacol
Zhang C, Xu J, Gu M, Tang Y, Tang W, Wang J, Liu Q, Yang Y, Zhong X, Xu C.   +9 more
europepmc   +1 more source

Angioimmunoblastic T-Cell Lymphoma

Hematology/Oncology Clinics of North America, 2017
Angioimmunoblastic T-cell lymphoma is a follicular T-helper-derived neoplasm displaying a peculiar morphologic appearance and biological complexity. New mutations have been described that contribute to elucidating the underlying pathogenetic events. The disease behaves aggressively and typically affects elderly patients.
BROCCOLI, ALESSANDRO, ZINZANI, PIER LUIGI   +1 more
core   +5 more sources

Angioimmunoblastic T-cell lymphoma

Critical Reviews in Oncology/Hematology, 2008
Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive neoplasm clinically characterized by sudden onset of constitutional symptoms, lymphadenopathy, hepatosplenomegaly, frequent autoimmune phenomena, particularly hemolytic anemia and thrombocytopenia, and polyclonal hypergammaglobulinemia.
IANNITTO, EMILIO, Ferreri, A., MINARDI, Viviana Maria, TRIPODO, Claudio, Kreipe, H.   +4 more
core   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Evaluation of cutaneous angioimmunoblastic T-cell lymphoma

Journal of the American Academy of Dermatology, 2011
Angioimmunoblastic T-cell lymphoma (AITL) accounts for 18% of peripheral T-cell lymphomas worldwide. Skin involvement occurs in up to 50% of patients but poses a diagnostic dilemma because of the limited number of reported cases and subsequent lack of established diagnostic criteria.The purpose of this review is to examine common clinical, histologic ...
Brundha, Balaraman, Jarod A, Conley, David M, Sheinbein   +2 more
exaly   +3 more sources

Angioimmunoblastic T‐cell lymphoma

British Journal of Haematology, 2003
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15–20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Ahmet, Dogan, Ayoma D, Attygalle, Chara, Kyriakou   +2 more
openaire   +3 more sources

Angioimmunoblastic T-Cell Lymphoma

2018
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Mariko, Yabe, Ahmet, Dogan, Steven M, Horwitz, Alison J, Moskowitz   +3 more
  +5 more sources

Angioimmunoblastic T-Cell Lymphoma

2013
Angioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma that is associated with systemic manifestations and involves lymph nodes. The neoplasm is morphologically characterized by a polymorphous infiltrate associated with prominent high endothelial venules and follicular dendritic cell proliferation.
Benjamin J. Chen, Dick G. Hwang
  +4 more sources

Angioimmunoblastic T-Cell Lymphoma Management

Seminars in Hematology, 2014
Angioimmunoblastic T-cell lymphoma (AITL) is a frequent subtype of peripheral T-cell lymphoma (PTCL) that is clinically characterized by generalized lymphadenopathy, extranodal involvement, advanced stage at presentation, hypergammaglobulinemia, and significant immune dysregulation resulting in infections as the most common cause of death.
Kailash, Mosalpuria, R Gregory, Bociek, Julie M, Vose   +2 more
openaire   +2 more sources